Healthy Adult Participants Clinical Trial
Official title:
A Phase 1, First-in-Human, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose and Food Effect Study of PORT-77 Administered Orally to Healthy Adult Participants
A First-in-Human 2-part, randomized, double-blind, placebo-controlled, single ascending dose, multiple ascending dose, and food effect, investigation of the administration of PORT-77 in healthy adult participants.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05578846 -
Bioequivalence Between 180 mg and 60 mg ALXN2050 Tablets and Food Effect on ALXN2050 Pharmacokinetics
|
Phase 1 | |
| Recruiting |
NCT06208488 -
A Study of Subcutaneous Gefurulimab Using Prefilled Syringe Versus Autoinjector in Healthy Adult Participants
|
Phase 1 | |
| Recruiting |
NCT06342713 -
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035
|
Phase 1 | |
| Completed |
NCT04540627 -
Exploratory Study to Estimate the Prophylactic Efficacy of Palivizumab in Healthy Adult Participants Inoculated With RSV
|
Phase 1 | |
| Recruiting |
NCT06278389 -
Single Ascending Dose, Food Effects and Drug-Drug Interactions of ACC017 Tablets in Healthy Adult Participants
|
Phase 1 | |
| Completed |
NCT03437564 -
A Bioequivalence Study of the Lu AA21004 20 mg and 2×10 mg Tablets
|
Phase 1 |